Identification of galectin-1 as a novel mediator for chemoresistance in chronic myeloid leukemia cells.
about
Galectin-1 knockdown improves drug sensitivity of breast cancer by reducing P-glycoprotein expression through inhibiting the Raf-1/AP-1 signaling pathwayAnnexin A2 could enhance multidrug resistance by regulating NF-κB signaling pathway in pediatric neuroblastoma.Emodin reverses leukemia multidrug resistance by competitive inhibition and downregulation of P-glycoprotein.Role of Galectins in Tumors and in Clinical Immunotherapy.Treatment of B-cell precursor acute lymphoblastic leukemia with the Galectin-1 inhibitor PTX008.Immune-Mediated and Hypoxia-Regulated Programs: Accomplices in Resistance to Anti-angiogenic Therapies.
P2860
Identification of galectin-1 as a novel mediator for chemoresistance in chronic myeloid leukemia cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 March 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Identification of galectin-1 a ...... hronic myeloid leukemia cells.
@en
Identification of galectin-1 a ...... hronic myeloid leukemia cells.
@nl
type
label
Identification of galectin-1 a ...... hronic myeloid leukemia cells.
@en
Identification of galectin-1 a ...... hronic myeloid leukemia cells.
@nl
prefLabel
Identification of galectin-1 a ...... hronic myeloid leukemia cells.
@en
Identification of galectin-1 a ...... hronic myeloid leukemia cells.
@nl
P2093
P2860
P356
P1433
P1476
Identification of galectin-1 a ...... hronic myeloid leukemia cells.
@en
P2093
Cai-Rong Zhu
Ji-Zhong Wang
Jian-Zhang Wu
Xi-Lei Chen
Xiang-Feng Zeng
Xiang-Peng Tan
P2860
P304
26709-26723
P356
10.18632/ONCOTARGET.8489
P407
P577
2016-03-30T00:00:00Z